Header

UZH-Logo

Maintenance Infos

Bevacizumab plus CCNU bei Rezidiv-Glioblastom. Der neue Standard?


Weller, Michael (2015). Bevacizumab plus CCNU bei Rezidiv-Glioblastom. Der neue Standard? InFo Onkologie, 18(3):18.

Statistics

Altmetrics

Downloads

2 downloads since deposited on 27 May 2015
0 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, not refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2015
Deposited On:27 May 2015 13:50
Last Modified:05 Apr 2016 19:16
Publisher:Springer Medizin
ISSN:1613-3633
Additional Information:Kommentar von Prof. Dr. med. Michael Weller : Die EORTC-Studie 26101 wird weitere Antworten geben
Publisher DOI:https://doi.org/10.1007/s15004-015-0804-y

Download

Preview Icon on Download
Filetype: PDF - Registered users only
Size: 114kB
View at publisher

Author Collaborations